Consolidated Statements of Shareholder's Equity (Unaudited) - USD ($) $ in Millions | Total | Cumulative Effect, Period of Adoption, Adjustment | Common Shares Outstanding | Additional Paid-in Capital | Additional Paid-in CapitalCumulative Effect, Period of Adoption, Adjustment | Retained Deficit | Retained DeficitCumulative Effect, Period of Adoption, Adjustment | Treasury Shares | Accumulated Other Comprehensive Income (Loss) |
Beginning balance at Dec. 31, 2019 | $ 563.1 | | | $ 844.8 | | $ (301.5) | | $ (24.9) | $ 44.7 |
Beginning balance (in shares) at Dec. 31, 2019 | | | 44,820,153 | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Net income (loss) | (19.9) | | | | | (19.9) | | | |
Other comprehensive income (loss) | (2.9) | | | | | | | | (2.9) |
Stock-based compensation expense | 2 | | | 2 | | | | | |
Issuance of treasury shares | | | | (5.7) | | | | 5.7 | |
Issuance of treasury shares (in shares) | | | 215,708 | | | | | | |
Shares surrendered for taxes | (0.2) | | | | | | | (0.2) | |
Shares surrendered for taxes (in shares) | | | (70,033) | | | | | | |
Ending balance at Mar. 31, 2020 | 542.1 | | | 841.1 | | (321.4) | | (19.4) | 41.8 |
Ending balance (in shares) at Mar. 31, 2020 | | | 44,965,828 | | | | | | |
Beginning balance at Dec. 31, 2019 | 563.1 | | | 844.8 | | (301.5) | | (24.9) | 44.7 |
Beginning balance (in shares) at Dec. 31, 2019 | | | 44,820,153 | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Net income (loss) | (35.2) | | | | | | | | |
Other comprehensive income (loss) | (4.2) | | | | | | | | |
Ending balance at Jun. 30, 2020 | 527 | | | 840.7 | | (336.7) | | (17.5) | 40.5 |
Ending balance (in shares) at Jun. 30, 2020 | | | 45,036,176 | | | | | | |
Beginning balance at Mar. 31, 2020 | 542.1 | | | 841.1 | | (321.4) | | (19.4) | 41.8 |
Beginning balance (in shares) at Mar. 31, 2020 | | | 44,965,828 | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Net income (loss) | (15.3) | | | | | (15.3) | | | |
Other comprehensive income (loss) | (1.3) | | | | | | | | (1.3) |
Stock-based compensation expense | 1.6 | | | 1.6 | | | | | |
Issuance of treasury shares | | | | (2) | | | | 2 | |
Issuance of treasury shares (in shares) | | | 75,689 | | | | | | |
Shares surrendered for taxes | (0.1) | | | | | | | (0.1) | |
Shares surrendered for taxes (in shares) | | | (5,341) | | | | | | |
Ending balance at Jun. 30, 2020 | 527 | | | 840.7 | | (336.7) | | (17.5) | 40.5 |
Ending balance (in shares) at Jun. 30, 2020 | | | 45,036,176 | | | | | | |
Beginning balance at Dec. 31, 2020 | 507.5 | $ (6.4) | | 843.4 | $ (10.6) | (363.4) | $ 4.2 | (12.9) | 40.4 |
Beginning balance (in shares) at Dec. 31, 2020 | | | 45,164,308 | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Net income (loss) | 9.8 | | | | | 9.8 | | | |
Other comprehensive income (loss) | (1.4) | | | | | | | | (1.4) |
Stock-based compensation expense | 1.8 | | | 1.8 | | | | | |
Stock option activity | 2.5 | | | 2.5 | | | | | |
Issuance of treasury shares | | | | (12.4) | | | | 12.4 | |
Issuance of treasury shares (in shares) | | | 580,248 | | | | | | |
Shares surrendered for taxes | (0.5) | | | | | | | (0.5) | |
Shares surrendered for taxes (in shares) | | | (72,174) | | | | | | |
Ending balance at Mar. 31, 2021 | 513.3 | | | 824.7 | | (349.4) | | (1) | 39 |
Ending balance (in shares) at Mar. 31, 2021 | | | 45,672,382 | | | | | | |
Beginning balance at Dec. 31, 2020 | 507.5 | $ (6.4) | | 843.4 | $ (10.6) | (363.4) | $ 4.2 | (12.9) | 40.4 |
Beginning balance (in shares) at Dec. 31, 2020 | | | 45,164,308 | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Net income (loss) | 63.8 | | | | | | | | |
Other comprehensive income (loss) | (2.5) | | | | | | | | |
Ending balance at Jun. 30, 2021 | 570 | | | 827.5 | | (295.4) | | | 37.9 |
Ending balance (in shares) at Jun. 30, 2021 | | | 46,088,954 | | | | | | |
Beginning balance at Mar. 31, 2021 | 513.3 | | | 824.7 | | (349.4) | | (1) | 39 |
Beginning balance (in shares) at Mar. 31, 2021 | | | 45,672,382 | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | |
Net income (loss) | 54 | | | | | 54 | | | |
Other comprehensive income (loss) | (1.1) | | | | | | | | (1.1) |
Stock-based compensation expense | 1.8 | | | 1.8 | | | | | |
Stock-based compensation expense (in shares) | | | 178,886 | | | | | | |
Stock option activity | 0.7 | | | 0.7 | | | | | |
Stock option activity (in shares) | | | 66,615 | | | | | | |
Issuance of treasury shares | | | | (1) | | | | $ 1 | |
Issuance of treasury shares (in shares) | | | 57,845 | | | | | | |
Convertible notes settlement | 1.3 | | | 1.3 | | | | | |
Convertible notes settlement (in shares) | | | 113,226 | | | | | | |
Ending balance at Jun. 30, 2021 | $ 570 | | | $ 827.5 | | $ (295.4) | | | $ 37.9 |
Ending balance (in shares) at Jun. 30, 2021 | | | 46,088,954 | | | | | | |